Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-in Capital	Accumulated  Deficit	Accumulated  Deficit Cumulative Effect, Period of Adoption, Adjustment	Cumulative Translation  Adjustments
Beginning balance (in shares) at Dec. 31, 2022			74,567
Beginning balance at Dec. 31, 2022	$ 28,672	$ (29)	$ 74	$ 214,094	$ (185,493)	$ (29)	$ (3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock (in shares)			414
Issuance of restricted stock	1		$ 1
Share-based compensation (in shares)			25
Share-based compensation	4,751			4,751
Translation adjustment	(1)						(1)
Net income (loss)	(4,938)				(4,938)
Ending balance (in shares) at Dec. 31, 2023			74,981
Ending balance at Dec. 31, 2023	28,456	(29)	$ 75	218,845	(190,460)		(4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock (in shares)			271
Issuance of restricted stock	0
Exercise of stock options (in shares)			2,053
Exercise of stock options	5,432		$ 2	5,430
Share-based compensation	3,656			3,656
Net income (loss)	8,550				8,550
Ending balance (in shares) at Dec. 31, 2024			77,330
Ending balance at Dec. 31, 2024	$ 46,094	$ 0	$ 77	$ 227,931	$ (181,910)		$ (4)